Expect Equity LLC Invests $1.37 Million in Viemed Healthcare, Inc. (NASDAQ:VMD)

Expect Equity LLC acquired a new stake in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 170,666 shares of the company's stock, valued at approximately $1,369,000. Expect Equity LLC owned about 0.44% of Viemed Healthcare at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. R Squared Ltd purchased a new stake in Viemed Healthcare in the fourth quarter valued at approximately $41,000. Corton Capital Inc. bought a new stake in shares of Viemed Healthcare during the 4th quarter worth $82,000. EntryPoint Capital LLC purchased a new position in shares of Viemed Healthcare in the 4th quarter worth about $92,000. Prudential Financial Inc. purchased a new position in shares of Viemed Healthcare in the 4th quarter worth about $93,000. Finally, Oxford Asset Management LLP purchased a new position in shares of Viemed Healthcare in the 4th quarter worth about $98,000. Institutional investors own 74.24% of the company's stock.

Viemed Healthcare Trading Up 3.0%

Shares of NASDAQ VMD traded up $0.19 during midday trading on Monday, reaching $6.51. The company had a trading volume of 329,270 shares, compared to its average volume of 141,714. Viemed Healthcare, Inc. has a one year low of $5.85 and a one year high of $9.81. The stock has a market cap of $257.30 million, a PE ratio of 24.11 and a beta of 1.49. The company has a quick ratio of 1.19, a current ratio of 1.31 and a debt-to-equity ratio of 0.03. The firm's fifty day moving average price is $7.07 and its 200-day moving average price is $7.91.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.06 EPS for the quarter, hitting the consensus estimate of $0.06. The firm had revenue of $59.10 million during the quarter, compared to analysts' expectations of $60.60 million. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.